SCHEMBL3593352

SCHEMBL3593352

COc1cc(C=CCC(F)(F)F)ccc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
MAPK1 P28482 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALOX15 P16050 1/20 0.46
NFE2L2 Q16236 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
NFKB1 P19838 2/20 0.44
ALOX5 P09917 1/20 0.44
HSD11B1 P28845 1/20 0.44
STAT3 P40763 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
APP P05067 2/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
PKM P14618 2/20 0.43
CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3583730 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL3589606 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL3583735 0.83 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL3593346 0.80 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL3910758 0.78 KDM4E (0.73) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL3910762 0.78 KDM4E (0.73) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL5692896 0.77 MAOB (0.62) ALDH1A1KDM4EHPGDMAPK1SMN1; SMN2
SCHEMBL5692899 0.77 MAOB (0.62) ALDH1A1KDM4EHPGDMAPK1SMN1; SMN2
SCHEMBL3909451 0.76 CYP2C9 (0.62) ALDH1A1KDM4EHPGDHSD17B10MAPK1
SCHEMBL6970963 0.75 EPHX2 (0.68) ALDH1A1KDM4EHPGDHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004222-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same RENOVIS, INC. (US) 2010-01-07 US disclosed
US-7576099-B2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same RENOVIS, INC. (US) 2009-08-18 US disclosed
US-20080300243-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same RENOVIS, INC. 2008-12-04 US disclosed
US-20060194801-A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same EVOTEC AG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004222-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same TRPV1, TRPA1, TRPV2 ALDH1A1 1265/4885KDM4E 4075/4885HPGD 510/4885
US-20060194801-A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same TRPV1, TRPA1, TRPV2 ALDH1A1 1821/4885KDM4E 4112/4885HPGD 573/4885
US-20080300243-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same TRPV1, TRPA1, TRPV2 ALDH1A1 1821/4885KDM4E 4112/4885HPGD 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.